Lexicon Pharmaceuticals
LXRX
$1.58
Share price
-0.32%
Change (1 day)
-34.10%
Change (1 year)
Categories
Lexicon Pharmaceuticals (LXRX) - Cash on Hand
Cash on Hand as of December 2023 : $0.17 B
According to Lexicon Pharmaceuticals
's latest financial reports the company has $0.17 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Lexicon Pharmaceuticals - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.13 B | 59.5% |
| 2021-12-31 | $86.74 M | -43.04% |
| 2020-12-31 | $0.15 B | -43.95% |
| 2019-12-31 | $0.27 B | 69.73% |
| 2018-12-31 | $0.16 B | -48.5% |
| 2017-12-31 | $0.31 B | -10.31% |
| 2016-12-31 | $0.34 B | -33.54% |
| 2015-12-31 | $0.52 B | 53.64% |
| 2014-12-31 | $0.33 B | 162.79% |
| 2013-12-31 | $0.12 B | -42.15% |
| 2012-12-31 | $0.22 B | -20.76% |
| 2011-12-31 | $0.28 B | 33.43% |
| 2010-12-31 | $0.21 B | 29.9% |
| 2009-12-31 | $0.16 B | 57.61% |
| 2008-12-31 | $0.10 B | -60.15% |
| 2007-12-31 | $0.25 B | 223.47% |
| 2006-12-31 | $79.99 M | -19.76% |
| 2005-12-31 | $99.69 M | 13.86% |
| 2004-12-31 | $87.55 M | -15.84% |
| 2003-12-31 | $0.10 B | 11.14% |
| 2002-12-31 | $93.6 M | -37.49% |
| 2001-12-31 | $0.14 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $8.07 B | 4,650.45% | 🇺🇸 USA |
 Illumina ILMN | $1.05 B | 519.91% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $10.84 B | 6,278.32% | 🇺🇸 USA |
 Ultragenyx RARE | $0.57 B | 239.48% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $0.17 B | 0.17% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $82.24 M | -51.63% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | $0.17 B | 1.43% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.07 B | 531.56% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $7.57 M | -95.54% | 🇺🇸 USA |